Publications: Prof Nicholas Croft

Klomberg RCW, van der Wal HC, Aardoom MA, Kemos P, Rizopoulos D, Ruemmele FM, Charrout M, Escher JC et al. ( 2023 ) . Improved clinical outcomes with early anti-tumour necrosis factor alpha therapy in children with newly diagnosed Crohn's disease: real world data from the international prospective PIBD-SETQuality inception cohort study . J Crohns Colitis

Adeniyi OF, Lesi OA, Odeghe EA, Oyeleke G, Croft N ( 2023 ) . Gastrointestinal Bleeding in Children: The Role of Endoscopy and the Sheffield Scoring System in a Resource-Limited Setting . JPGN Rep vol. 4 , ( 4 )

Croft NM, Korczowski B, Kierkuś J, Caballero B, Thakur MK ( 2023 ) . Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis: a phase 3, randomised, double-blind study . eClinicalMedicine vol. 65 ,

Bai BYH, Reppell M, Smaoui N, Waring JF, Pivorunas V, Guay H, Lin S, Chanchlani N et al. ( 2023 ) . Baseline expression of immune gene modules in blood is associated with primary response to anti-TNF therapy in Crohn's disease patients . J Crohns Colitis

Atia O, Klomberg RCW, de Ridder L, Kemos P, Ruemmele FM, Kang B, Choi S, Choe BH et al. ( 2023 ) . Validation of predictive models for disease outcomes in paediatric ulcerative colitis: A multicentre prospective inception cohort . Alimentary Pharmacology and Therapeutics vol. 58 , ( 2 ) 182 - 190 .

Marcovitch L, Focht G, Carmon N, Tersigni C, Ledder O, Lev-Tzion R, Church PC, Hyams JS et al. ( 2023 ) . Development and Validation of the TUMMY-UC: A Patient-Reported Outcome for Pediatric Ulcerative Colitis . Gastroenterology vol. 164 , ( 4 ) 610 - 618.e4 .

Cheng K, Mahler F, Lutsar I, Nafria Escalera B, Breitenstein S, Vassal G, Claverol J, Noel Palacio N et al. ( 2023 ) . Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children . Clinical and Translational Science vol. 16 , ( 3 ) 478 - 488 .

Liu Z, Le K, Zhou X, Alexander JL, Lin S, Bewshea C, Chanchlani N, Nice R et al. ( 2023 ) . Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study . The Lancet Gastroenterology and Hepatology vol. 8 , ( 2 ) 145 - 156 .

Croft NM, De Ridder L, Griffiths AM, Hyams JS, Ruemmele FM, Turner D, Cheng K, Lutsar I et al. ( 2023 ) . Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents . Journal of Crohn's and Colitis vol. 17 , ( 2 ) 249 - 258 .

Klomberg R, Kaper D, Barendregt D, Vuijk S, Schreurs M, Charrout M, Ruemmele F, Kemos P et al. ( 2023 ) . P243 The association between serological markers ASCA and ANCA and response to induction treatment in therapy-naïve children with inflammatory bowel disease: an international prospective study . Journal of Crohn's and Colitis . vol. 17 , i395 - i396 .

Klomberg R, Kaper D, Barendregt D, Vuijk S, Schreurs M, Charrout M, Ruemmele F, Kemos P et al. ( 2023 ) . The association between serological markers ASCA and ANCA and response to induction treatment in therapy-naive children with inflammatory bowel disease: an international prospective study . JOURNAL OF CROHNS & COLITIS . vol. 17 , I395 - I396 .

Serra EG, Schwerd T, Moutsianas L, Cavounidis A, Fachal L, Pandey S, Kammermeier J, Croft NM et al. ( 2022 ) . Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y) . Nature Communications vol. 13 , ( 1 )

Stodtmann S, Chen MJ, Siovitz L, Bereswill M, Lazar A, Croft N, Kierkus J, Faubion WA et al. ( 2022 ) . Bridging Fixed Dose to Body Weight-based Regimen of Adalimumab in Paediatric Ulcerative Colitis Using a Pharmacometric Modelling Approach: Case Study with the Phase 3 ENVISION I Trial . Journal of Crohn's and Colitis vol. 16 , ( 10 ) 1551 - 1561 .

Torrente F, Meade S, Benchimol EI, De Ridder L, Croft NM, Kammermeier J, Mack DR, Klomberg RCW et al. ( 2022 ) . Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel . Journal of Crohn's and Colitis vol. 16 , ( 10 ) 1609 - 1616 .

Hyams JS, Turner D, Cohen SA, Szakos E, Kowalska-Duplaga K, Ruemmele F, Croft NM, Korczowski B et al. ( 2022 ) . Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn's Disease: Results from the Phase 2 HUBBLE Study . Journal of Crohn's and Colitis vol. 16 , ( 8 ) 1243 - 1254 .

Klomberg RCW, Aardoom MA, Kemos P, Rizopoulos D, Ruemmele FM, Croft NM, de Ridder L, Neyt M et al. ( 2022 ) . High Impact of Pediatric Inflammatory Bowel Disease on Caregivers’ Work Productivity and Daily Activities: An International Prospective Study . Journal of Pediatrics vol. 246 , 95 - 102.e4 .

Mulberg AE, Conklin LS, Croft NM, Parikh A, Bousvaros A, DeZoeten E, Dubinsky M, Martin Carpi FJ et al. ( 2022 ) . Pediatric Extrapolation of Adult Efficacy to Children Is Critical for Efficient and Successful Drug Development . Gastroenterology vol. 163 , ( 1 ) 77 - 83 .

Gasparetto M, Burgess N, Naik S, Studart D, Kadir A, Croft N, Sanderson I, Deb P ( 2022 ) . Advantages of Proactive Therapeutic Drug Monitoring in a Prospective Cohort of Children With Inflammatory Bowel Disease Treated With Anti-TNF . J Pediatr Gastroenterol Nutr

Heredia M, Costes LMM, Tindemans I, Aardoom MA, Klomberg RCW, Kemos P, Joosse ME, van Haaften DH et al. ( 2022 ) . P045 TIGIT expression differentiates regulatory from inflammatory Th1* gut-homing effector CD4+ T cells in inflammatory bowel disease patients . Journal of Crohn's and Colitis . vol. 16 , i161 - i161 .

Heredia M, Charrout M, Klomberg RCW, Aardoom MA, Jongsma MME, Kemos P, van Haaften DH, Tuk B et al. ( 2022 ) . P061 Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course . Journal of Crohn's and Colitis . vol. 16 , i171 - i171 .

Klomberg R, van der Wal H, Sarbagili C, Kemos P, Ruemelle F, Croft N, de Ridder L, Levine A ( 2022 ) . P146 Initial response to induction treatment more important than type of induction treatment for achieving sustained steroid free remission at 1 year in new-onset paediatric Crohn’s disease . Journal of Crohn's and Colitis . vol. 16 , i226 - i226 .

Hansen R, Meade S, Torrente F, Kammermeier J, Croft NM, de Ridder L, Wilson DC, Klomberg R et al. ( 2022 ) . P590 Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel . Journal of Crohn's and Colitis . vol. 16 , i526 - i527 .

Klomberg R, Kemos P, Chondrou P, Croft N, de Ridder L ( 2022 ) . P678 Rare and severe complications in paediatric Inflammatory Bowel Disease: results of 5 years of international collaboration through the PIBD-SETQuality Safety Registry . Journal of Crohn's and Colitis . vol. 16 , i582 - i582 .

Heredia M, Charrout M, Klomberg RCW, Aardoom MA, Jongsma MME, Kemos P, van Haaften DH, Tuk B et al. ( 2022 ) . Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course . JOURNAL OF CROHNS & COLITIS . vol. 16 , I171 - I171 .

Klomberg R, van der Wal H, Sarbagili C, Kemos P, Ruemelle F, Croft N, de Ridder L, Levine A ( 2022 ) . Initial response to induction treatment more important than type of induction treatment for achieving sustained steroid free remission at 1 year in new-onset paediatric Crohn's disease . JOURNAL OF CROHNS & COLITIS . vol. 16 , I226 - I226 .

Klomberg R, Kemos P, Chondrou P, Croft N, de Ridder L ( 2022 ) . Rare and severe complications in paediatric Inflammatory Bowel Disease: results of 5 years of international collaboration through the PIBD-SETQuality Safety Registry . JOURNAL OF CROHNS & COLITIS . vol. 16 , I582 - I582 .

Heredia M, Costes LMM, Tindemans I, Aardoom MA, Klomberg RCW, Kemos P, Joosse ME, van Haaften DH et al. ( 2022 ) . TIGIT expression differentiates regulatory from inflammatory Th1*gut-homing effector CD4+T cells in inflammatory bowel disease patients . JOURNAL OF CROHNS & COLITIS . vol. 16 , I161 - I161 .

Hansen R, Meade S, Torrente F, Kammermeier J, Croft NM, de Ridder L, Wilson DC, Klomberg R et al. ( 2022 ) . Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel . JOURNAL OF CROHNS & COLITIS . vol. 16 , I526 - I527 .

Mcgregor CGC, Adams A, Sadler R, Arancibia-Cárcamo CV, Palmer R, Ambrose T, Brain O, Walsh A et al. ( 2021 ) . Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic . Gut vol. 70 , ( 12 ) 2398 - 2400 .

Berger TD, Lee HM, Padmanaban LR, Wine E, Yerushalmy-Feler A, Hojsak I, Kazeka D, Serban DE et al. ( 2021 ) . Clinical Features and Outcomes of Paediatric Patients with Isolated Colonic Crohn's Disease . J Pediatr Gastroenterol Nutr

Aardoom MA, Klomberg RCW, Kemos P, Ruemmele FM, van Ommen H, de Ridder L, Croft NM ( 2021 ) . The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease; a prospective international cohort study based on the PIBD-SETQuality Safety Registry . J Crohns Colitis

Walsh CM, Lightdale JR, Mack DR, Amil-Dias J, Bontems P, Brill H, Croft NM, Fishman DS et al. ( 2021 ) . Overview of the Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Quality Standards and Indicators for Pediatric Endoscopy: A Joint NASPGHAN/ESPGHAN Guideline . J Pediatr Gastroenterol Nutr

Lightdale JR, Walsh CM, Fishman DS, Furlano RI, Mamula P, Gillett PM, Narula P, Hojsak I et al. ( 2021 ) . Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Pediatric Endoscopy Reporting Elements: A Joint NASPGHAN/ESPGHAN Guideline . J Pediatr Gastroenterol Nutr

Lightdale JR, Walsh CM, Oliva S, Jacobson K, Huynh HQ, Homan M, Hojsak I, Gillett PM et al. ( 2021 ) . Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Quality Standards and Indicators for Pediatric Endoscopic Procedures: A Joint NASPGHAN/ESPGHAN Guideline . J Pediatr Gastroenterol Nutr

Walsh CM, Lightdale JR, Leibowitz IH, Lerner DG, Liu QY, Mack DR, Mamula P, Narula P et al. ( 2021 ) . Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Quality Standards and Indicators for Pediatric Endoscopists and Endoscopists in Training: A Joint NASPGHAN/ESPGHAN Guideline . J Pediatr Gastroenterol Nutr

Lightdale JR, Walsh CM, Narula P, Utterson EC, Tavares M, Rosh JR, Riley MR, Oliva S et al. ( 2021 ) . Pediatric Endoscopy Quality Improvement Network (PEnQuIN) Quality Standards and Indicators for Pediatric Endoscopy Facilities: A Joint NASPGHAN/ESPGHAN Guideline . J Pediatr Gastroenterol Nutr

Croft NM, Faubion WA, Kugathasan S, Kierkus J, Ruemmele FM, Shimizu T, Mostafa NM, Venetucci M et al. ( 2021 ) . Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study . The Lancet Gastroenterology and Hepatology vol. 6 , ( 8 ) 616 - 627 .

Hansen R, Meade S, Beattie RM, Auth MKH, Croft N, Davies P, Devadason D, Doherty C et al. ( 2021 ) . Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: A RAND appropriateness panel . Gut vol. 70 , ( 6 ) 1044 - 1052 .

Kennedy NA, Goodhand J, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J et al. ( 2021 ) . OP03 Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab . Journal of Crohn's and Colitis . vol. 15 , s002 - s004 .

Berger T, Lee HM, Padmanaban LR, Wine E, Yerushalmi A, Hojsak I, Bronski J, Serban D et al. ( 2021 ) . OP16 Characterization of the Clinical Features and Outcomes of Paediatric Patients with Isolated Colonic Crohn’s Disease: A Multi-center Study from the Porto Group of ESPGHAN . Journal of Crohn's and Colitis . vol. 15 , s015 - s016 .

Heredia M, Costes L, Tindemans I, Aardoom M, Klomberg R, Kemos P, Joosse M, van Haaften D et al. ( 2021 ) . P012 Low frequencies of circulating inhibitory TIGIT+CD38+ effector T cells identify an immunologically distinct subgroup of pediatric patients with severe Crohn’s disease . Journal of Crohn's and Colitis . vol. 15 , s134 - s134 .

Heredia M, Charrout M, Klomberg R, Aardoom M, Jongsma M, Kemos P, van Haaften D, Tuk B et al. ( 2021 ) . P021 Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course . Journal of Crohn's and Colitis . vol. 15 , s139 - s139 .

Klomberg R, Kemos P, Aardoom M, Rizopoulos D, Croft N, de Ridder L, Neyt M ( 2021 ) . P114 Frequent work productivity and activity impairment in caregivers of children with inflammatory bowel disease: a project of the prospective PIBD-SETQuality inception cohort study . Journal of Crohn's and Colitis . vol. 15 , s206 - s207 .

Mardare R, Burgess N, Studart D, Deb P, Gasparetto M, Croft N, Naik S, Kadir A ( 2021 ) . P386 Two year follow up of children with Inflammatory Bowel Disease (IBD) treated with vedolizumab and ustekinumab . Journal of Crohn's and Colitis . vol. 15 , s397 - s398 .

Klomberg R, Aardoom M, Kemos P, Ruemmele F, Van Ommen CH, Croft NM, De Ridder L ( 2021 ) . 730 INCREASED RISK OF VENOUS THROMBOEMBOLISM IN PAEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE - A STUDY OF THE INTERNATIONAL PROSPECTIVE SAFETY REGISTRY . Gastroenterology . vol. 160 , s - 146 .

Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J et al. ( 2021 ) . Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab . Gut vol. 70 , ( 5 ) 865 - 875 .

Hyams JS, Turner D, Cohen SA, Szakos E, Kowalska-Duplaga K, Ruemmele F, Croft NM, Korczowski B et al. ( 2021 ) . Su497 PHARMACOKINETICS (PK), SAFETY, AND EFFICACY OF INTRAVENOUS (IV) VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE: RESULTS FROM THE PHASE 2 HUBBLE STUDY . Gastroenterology . vol. 160 , s - 716 .

Klomberg R, Vuijk S, Kemos P, Aardoom M, Ruemmele F, Mulder J, Croft NM, De Ridder L ( 2021 ) . Su525 THE INCIDENCE AND CAUSES OF RENAL FAILURE IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE - A PROJECT OF THE PIBD-SETQ SAFETY REGISTRY . Gastroenterology . vol. 160 ,

Gasparetto M, Burgess N, Studart D, Naik S, Kadir A, Croft N, Sanderson I, Deb P ( 2021 ) . P07 A single-centre prospective observational study comparing proactive with reactive therapeutic drug monitoring (TDM) in two cohorts of children with inflammatory bowel disease (IBD) . Frontline Gastroenterology . Conference: British Society of Paediatric Gastroenterology, Hepatology and Nutrition vol. 12 , a13 - a14 .

Thorn N, Vallorani M, Kirupananthan R, Kemos P, Croft N ( 2021 ) . P20 Emergenci: a UK prospective survey of severe GI bleeding (requiring upper GI endoscopy) and emergency endoscopy in under 16s . Frontline Gastroenterology . Conference: Poster presentations vol. 12 , a22 - a23 .

Mardare R, Burgess N, Studart D, Deb P, Gasparetto M, Croft N, Kadir A, Naik S ( 2021 ) . P56 Two year follow up of children with inflammatory bowel disease (IBD) treated with Vedolizumab and Ustekinumab . Frontline Gastroenterology . Conference: Poster presentations vol. 12 , a46 - a46 .

Shea T, Athanasakos E, Cleeve S, Croft N, Gibbs D ( 2021 ) . Pediatric Medical Traumatic Stress . The Journal of Child Life Psychosocial Theory and Practice vol. 2 , ( 1 )

Shea T, Athanasakos E, Cleeve S, Croft N, Gibbs D ( 2021 ) . Pediatric medical traumatic stress: A scoping review . The Journal of Child Life: Psychosocial Theory and Practice vol. 2 , ( 1 ) 44 - 54 .

Berger T, Lee MH, Padmanaban RL, Wine E, Yerushalmi A, Hojsak I, Bronski J, Serban D et al. ( 2021 ) . Characterization of the Clinical Features and Outcomes of Paediatric Patients with Isolated Colonic Crohn's Disease: A Multi-center Study from the Porto Group of ESPGHAN . JOURNAL OF CROHNS & COLITIS . vol. 15 , S015 - S016 .

Heredia M, Charrout M, Klomberg RCW, Aardoom MA, Jongsma MME, Kemos P, van Haaften DH, Tuk B et al. ( 2021 ) . Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course . EUROPEAN JOURNAL OF IMMUNOLOGY . vol. 51 , 275 - 275 .

Klomberg R, Aardoom M, Kemos P, Ruemmele F, Van Ommen CHH, Croft NM, De Ridder L ( 2021 ) . INCREASED RISK OF VENOUS THROMBOEMBOLISM IN PAEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE - A STUDY OF THE INTERNATIONAL PROSPECTIVE SAFETY REGISTRY . GASTROENTEROLOGY . vol. 160 , S146 - S146 .

Neyt M, Christiaens A, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D et al. ( 2021 ) . Identifying health economic considerations to include in the research protocol of a randomized controlled trial (the REDUCE-RISK Trial): Systematic literature review and assessment . JMIR Formative Research vol. 5 , ( 1 )

Klomberg R, Vuijk S, Kemos P, Aardoom M, Ruemmele F, Mulder J, Croft NM, De Ridder L ( 2021 ) . THE INCIDENCE AND CAUSES OF RENAL FAILURE IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE - A PROJECT OF THE PIBD-SETQ SAFETY REGISTRY . GASTROENTEROLOGY . vol. 160 , S726 - S727 .

Heredia M, Costes LMM, Tindemans I, Aardoom MA, Klomberg RCW, Kemos P, Joosse ME, Van Haaften DH et al. ( 2021 ) . TIGIT expression differentiates regulatory from inflammatory non-classical Th1-like gut-homing effector CD4+T cells in inflammatory bowel disease patients . EUROPEAN JOURNAL OF IMMUNOLOGY . vol. 51 , 29 - 29 .

Tan ZV, Kosana K, Savarino J, Croft N, Naik S, Kaplan J, Giles E ( 2020 ) . Histology at diagnostic gastroscopy predicts outcome after intestinal resection in pediatric Crohn's disease . Journal of Gastroenterology and Hepatology (Australia) vol. 35 , ( 12 ) 2074 - 2079 .

Serra EG, Schwerd T, Moutsianas L, Cavounidis A, Fachal L, Pandey S, Kammermeier J, Croft NM et al. ( 2020 ) . Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease . Nature Communications vol. 11 , ( 1 )

Aardoom MA, Kemos P, Tindemans I, Aloi M, Koletzko S, Levine A, Turner D, Veereman G et al. ( 2020 ) . International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study . BMJ open vol. 10 , ( 7 ) e035538 - e035538 .

Harris RE, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D, Veereman G et al. ( 2020 ) . Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course . BMJ open vol. 10 , ( 7 ) e034892 - e034892 .

Aardoom M, Kemos P, Ruemmele F, van Ommen CH, Croft NM, de Ridder L ( 2020 ) . Mo1900 THE INCIDENCE AND CHARACTERISTICS OF VENOUS THROMBOEMBOLISMS IN PEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE . Gastroenterology . vol. 158 , s - 970 .

Costes L, Tindemans I, Joosse ME, Aardoom MA, Jongsma MME, Raatgeep RHC, van Haaften DH, Alexander KL et al. ( 2020 ) . DOP09 IgG responses to multiple bacterial flagellins identify a subgroup of paediatric therapy-naive Crohn’s disease patients with increased microbiota-specific T-cell reactivity . Journal of Crohn's and Colitis . vol. 14 , s046 - s046 .

Aardoom M, Kemos P, Ruemmele FM, van Ommen CH, Croft NM, de Ridder L ( 2020 ) . P116 The occurrence of venous thromboembolisms in paediatric-onset IBD . Journal of Crohn's and Colitis . vol. 14 , s194 - s194 .

Costes L, Tindemans I, Joosse ME, Aardoom MA, Jongsma MME, Raatgeep RHC, van Haaften DH, Alexander KL et al. ( 2020 ) . IgG responses to multiple bacterial flagellins identify a subgroup of paediatric therapynaive Crohn's disease patients with increased microbiota-specific T-cell reactivity . JOURNAL OF CROHNS & COLITIS . vol. 14 , S046 - S046 .

Aardoom M, Kemos P, Ruemmele F, van Ommen CHH, Croft NM, de Ridder L ( 2020 ) . THE INCIDENCE AND CHARACTERISTICS OF VENOUS THROMBOEMBOLISMS IN PEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE .

Aardoom M, Kemos P, Ruemmele FM, van Ommen CH, Croft NM, de Ridder L ( 2020 ) . The occurrence of venous thromboembolisms in paediatric-onset IBD . JOURNAL OF CROHNS & COLITIS . vol. 14 , S194 - S194 .

Sazonovs A, Kennedy NA, Moutsianas L, Heap GA, Rice DL, Reppell M, Bewshea CM, Chanchlani N et al. ( 2019 ) . HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease . Gastroenterology vol. 158 , ( 1 ) 189 - 199 .

De Jesus H, Ooms A, Norton C, Dibley L, Croft N ( 2019 ) . Development of self-management in pediatric inflammatory bowel disease: A qualitative exploration . Journal of Nursing Education and Practice vol. 9 , ( 11 ) 75 - 75 .

Krauthammer A, Tzivinikos C, Assa A, Miele E, Strisciuglio C, Urlep D, Serban ED, Singh A et al. ( 2019 ) . Long-term Outcomes of Paediatric Patients Admitted with Acute Severe Colitis - A Multicenter Study from the Paediatric IBD Porto Group of ESPGHAN . J Crohns Colitis

Rao A, Kemos P, Kamperidis N, Naik S, Croft NM, Sanderson I ( 2019 ) . CHILDREN WITH CROHN'S DISEASE WHO RESPOND TO AN ENTERAL DIET ARE TWICE AS LIKELY TO REMAIN IN CLINICAL REMISSION OVER 5 YEARS . GASTROENTEROLOGY . Conference: Digestive Diseases Week (American Gastroenterological Association) vol. 156 , S615 - S616 .

Vavilikolanu R, Sanderson I, Naik S, Croft NM, Kemos P ( 2019 ) . G118(P) The risk of nephrotoxicity from 5-ASA in children with ulcerative colitis (UC) is not dose related . Archives of Disease in Childhood . Conference: Royal College of Paediatrics and Child Health vol. 104 , a48 - a48 .

Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R et al. ( 2019 ) . Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study . The Lancet Gastroenterology and Hepatology vol. 4 , ( 5 ) 341 - 353 .

Rao A, Kemos P, Kamperidis N, Naik S, Croft NM, Sanderson I ( 2019 ) . Su1797 – Children with Crohn’s Disease Who Respond to an Enteral Diet are Twice As Likely to Remain in Clinical Remission Over 5 Years . Gastroenterology . vol. 156 ,

Walker GJ, Harrison JW, Heap GA, Voskuil MD, Andersen V, Anderson CA, Ananthakrishnan AN, Barrett JC et al. ( 2019 ) . Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease . JAMA vol. 321 , ( 8 ) 773 - 785 .

Aardoom MA, Kemos P, Ruemmele F, Tindemans I, Samsom JN, Croft N, de Ridder L ( 2019 ) . P165 A global prospective observational study in children and adolescents with paediatric-onset IBD: the PIBD-SETQuality inception cohort . Journal of Crohn's and Colitis . vol. 13 , s171 - s172 .

Aardoom MA, Kemos P, Ruemmele F, Croft N, de Ridder L ( 2019 ) . P596 An ongoing safety registry to identify rare and severe complications in children with paediatric-onset IBD . Journal of Crohn's and Colitis . vol. 13 , s413 - s413 .

Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M et al. ( 2018 ) . Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition . J Pediatr Gastroenterol Nutr vol. 67 , ( 2 ) 257 - 291 .

Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M et al. ( 2018 ) . Management of Paediatric Ulcerative Colitis, Part 2: Acute Severe Colitis-An Evidence-based Consensus Guideline From the European Crohn's and Colitis Organization and the European Society of Paediatric Gastroenterology, Hepatology and Nutrition . J Pediatr Gastroenterol Nutr vol. 67 , ( 2 ) 292 - 310 .

Auth MK-K, Bunn SK, Protheroe AL, Williams LJ, Fell JM, Muhammed R, Croft NM, Beattie RM et al. ( 2018 ) . Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom . Inflamm Bowel Dis vol. 24(7) , ( Jun 8 ) 1520 - 1530 .

Crane MB, Grant A, Hyams J, Croft N, Mack DR, Hussey S, Sylvester F, Huynh HQ et al. ( 2018 ) . A132 DEVELOPMENT OF THE TUMMY-CD, A SYMPTOMS-BASED DISEASE ACTIVITY PATIENT REPORTED OUTCOME (PRO) FOR PEDIATRIC CROHN’S DISEASE . Journal of the Canadian Association of Gastroenterology . vol. 1 , 197 - 198 .

Schwerd T, Bryant RV, Pandey S, Capitani M, Meran L, Cazier JB, Jung J, Mondal K et al. ( 2018 ) . NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease . Mucosal Immunology vol. 11 , ( 2 ) 562 - 574 .

Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MKH, Elawad M, Fell JME, Beattie RM et al. ( 2018 ) . Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response . J Pediatr Gastroenterol Nutr vol. 66 , ( 2 ) 274 - 280 .

Marcovitz L, Nissan A, Horesh A, Mack D, Hussey S, Otley A, Croft N, Kappelman M et al. ( 2018 ) . P133 Cognitive debriefing interviews (phase 2B) towards developing a Patient Reported Outcome measure for Paediatric ulcerative colitis- the TUMMY-UC . Journal of Crohn's and Colitis . vol. 12 , s161 - s162 .

Aardoom M, Kemos P, Ruemmele F, Croft N, de Ridder L, consortium and PIBDnet OBOTPS ( 2018 ) . P584 Rare and severe complications in children with paediatric-onset IBD; the international PIBD SETQuality Safety Registry by PIBDnet . Journal of Crohn's and Colitis . vol. 12 , s403 - s404 .

Kemos P, Aardoom M, Ruemmele F, de Ridder L, Croft N, consortium and PIBDnet OBOTPS ( 2018 ) . P785 Designing the first pan-European paediatric IBD database to allow the study of incidence and prevalence of UC, CD, and their rare and severe complications . Journal of Crohn's and Colitis . vol. 12 , s508 - s508 .

Marcovitz L, Nissan A, Horesh A, Mack D, Hussey S, Otley A, Croft N, Kappelman M et al. ( 2018 ) . Cognitive debriefing interviews (phase 2B) towards developing a Patient Reported Outcome measure for Paediatric ulcerative colitis- the TUMMY-UC . JOURNAL OF CROHNS & COLITIS . vol. 12 , S161 - S162 .

Kemos P, Aardoom M, Ruemmele F, de Ridder L, Croft N ( 2018 ) . Designing the first pan-European paediatric IBD database to allow the study of incidence and prevalence of UC, CD, and their rare and severe complications . JOURNAL OF CROHNS & COLITIS . vol. 12 , S508 - S508 .

Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, De Carpi JM, Bronsky J, Veres G, Aloi M et al. ( 2018 ) . Management of paediatric ulcerative colitis, part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition . Journal of Pediatric Gastroenterology and Nutrition vol. 67 , ( 2 ) 257 - 291 .

Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, De Carpi JM, Bronsky J, Veres G, Aloi M et al. ( 2018 ) . Management of paediatric ulcerative colitis, part 2: Acute severe colitis - An evidence-based consensus guideline from the european Crohn's and colitis organization and the european society of paediatric gastroenterology, hepatology and nutrition . Journal of Pediatric Gastroenterology and Nutrition vol. 67 , ( 2 ) 292 - 310 .

Aardoom M, Kemos P, Ruemmele F, Croft N, de Ridder L ( 2018 ) . Rare and severe complications in children with paediatric-onset IBD; the international PIBD SETQuality Safety Registry by PIBDnet . JOURNAL OF CROHNS & COLITIS . vol. 12 , S403 - S404 .

Wang S, Younus O, Rawat D, Naik S, Giles E, Meadows N, Croft NM ( 2017 ) . Clinical Presentation and Outcomes of Diagnostic Endoscopy in Newly Presenting Children with Gastrointestinal Symptoms . J Pediatr Gastroenterol Nutr

Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MK, Elawad M, Fell JM, Beattie RM et al. ( 2017 ) . Real-Life Anti-Tumour Necrosis Factor Experience in > 500 Paediatric United Kingdom Inflammatory Bowel Disease Patients . J Pediatr Gastroenterol Nutr

CROFT NM, GILES E ( 2017 ) . Autoimmune Gastropathy . Esophageal and Gastric Disorders in Infancy and Childhood , Springer

Marcovitch L, Nissan A, Mack D, Otley A, Hussey S, Mclean B, Lewis M, Croft N et al. ( 2017 ) . Item Generation and Reduction Toward Developing a Patient-reported Outcome for Pediatric Ulcerative Colitis (TUMMY-UC) . J Pediatr Gastroenterol Nutr vol. 64 , ( 3 ) 373 - 377 .

Tranter M, Barakat F, Dogra H, Lindsay J, Croft N, Bulmer D ( 2017 ) . MMP-12, a novel mediator of nociception in Crohn's disease . JOURNAL OF CROHNS & COLITIS . Conference: European Crohn's and Colitis (ECCO) Congress 2017 vol. 11 , S120 - S120 .

Tranter M, Barakat F, Dogra H, Lindsay J, Croft N, Bulmer D ( 2017 ) . P086 MMP-12, a novel mediator of nociception in Crohn's disease . J Crohns Colitis . vol. 11 , S120 - S120 .

Wang S, Younus O, Naik S, Rawat D, Meadows N, Giles E, Croft N ( 2016 ) . G31 Diagnostic endoscopy in newly presenting children with Gastrointestinal Symptoms: Indications and outcomes . Archives of Disease in Childhood . vol. 101 ,

Afzal N, Lloyd C, Narula P, Gupte G, Croft N, Baker A ( 2016 ) . G32 Variation in upper GI bleeding service provision for children in the United Kingdom – a nation-wide survey by British Society of Paediatric Gastroenterology Hepatology and Nutrition (BSPGHAN) . Archives of Disease in Childhood . vol. 101 ,

Croft NM, Faubion W, Tierens D, Dewulf J, Bwirire D, Stefani-Hunyady D, Cataldi F ( 2016 ) . Su1925 Feasibility of a Placebo-Controlled, Randomized Mesalamine Withdrawal Study in Children and Adolescents With Ulcerative Colitis . Gastroenterology . vol. 150 , s590 - s591 .

Croft N, Faubion W, Tierens D, Dewulf J, Bwirire D, Stefani-Hunyady D, Cataldi F ( 2016 ) . Indication-specific feasibility assessment of a placebo-controlled randomised mesalazine withdrawal study for paediatric patients with ulcerative colitis . JOURNAL OF CROHNS & COLITIS . vol. 10 , S336 - S337 .

Mt-Isa S, Tomlin S, Sutcliffe A, Underwood M, Williamson P, Croft NM, Ashby D ( 2015 ) . Prokinetics prescribing in paediatrics: Evidence on cisapride, domperidone, and metoclopramide . Journal of Pediatric Gastroenterology and Nutrition vol. 60 , ( 4 ) 508 - 514 .

Tranter M, Barakat F, Bulmer D, Croft N ( 2015 ) . How do IBD supernatants activate visceral sensory afferents? . NEUROGASTROENTEROLOGY AND MOTILITY . vol. 27 , 104 - 104 .

Johal A, Abed Al Jawad F, Marcenes W, Croft N ( 2013 ) . Does orthodontic treatment harm children's diets? . J Dent vol. 41 , ( 11 ) 949 - 954 .

Goodhand JR, Kamperidis N, Sirwan B, Macken L, Tshuma N, Koodun Y, Chowdhury FA, Croft NM et al. ( 2013 ) . Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease . Aliment Pharmacol Ther vol. 38 , ( 9 ) 1097 - 1108 .

Russell RK, Protheroe A, Roughton M, Croft NM, Murphy MS, Spray C, Rodrigues AF, Wilson DC et al. ( 2013 ) . Contemporary outcomes for ulcerative colitis inpatients admitted to pediatric hospitals in the United Kingdom . Inflamm Bowel Dis vol. 19 , ( 7 ) 1434 - 1440 .

Goodhand J, Kamperidis N, Sirwan B, Macken L, Tshuma N, Koodun Y, Chowdhury F, Croft N et al. ( 2013 ) . P335 Thiopurine nonadherence is more common in adolescents than adults with IBD, is associated with psychological distress and impacts on the management and prognosis . Journal of Crohn's and Colitis . vol. 7 , s144 - s144 .

Giles E, Hanci O, McLean A, Power N, Cole A, Croft NM, McDonald K, Chippington S et al. ( 2012 ) . Optimal assessment of paediatric IBD with MRI and barium follow-through . J Pediatr Gastroenterol Nutr vol. 54 , ( 6 ) 758 - 762 .

Russell RK, Protheroe A, Roughton M, Croft N, Murphy MS, Spray C, Rodrigues A, Wilson DC et al. ( 2012 ) . OC-050 Inpatient paediatric UC care in the UK in 2011 is characterised by increasing rates of rescue therapy and stool cultures but low use of pucai scores . Gut . vol. 61 ,

Kamperidis N, Goodhand JR, Chowdhury FA, Koodun Y, Direzke NC, Naik S, Sanderson IR, Croft NM et al. ( 2012 ) . Factors associated with nonadherence to thiopurines in adolescent and adult patients with inflammatory bowel disease . J Pediatr Gastroenterol Nutr vol. 54 , ( 5 ) 685 - 689 .

Goodhand JR, Kamperidis N, Joshi NM, Wahed M, Koodun Y, Cantor EJ, Croft NM, Langmead FL et al. ( 2012 ) . The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descent . Aliment Pharmacol Ther vol. 35 , ( 8 ) 929 - 940 .

Goodhand JR, Kamperidis N, Rao A, Laskaratos F, McDermott A, Wahed M, Naik S, Croft NM et al. ( 2012 ) . Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease . Inflamm Bowel Dis vol. 18 , ( 3 ) 513 - 519 .

Al Jawad FA, Cunningham SJ, Croft N, Johal A ( 2012 ) . A qualitative study of the early effects of fixed orthodontic treatment on dietary intake and behaviour in adolescent patients . EUROPEAN JOURNAL OF ORTHODONTICS vol. 34 , ( 4 ) 432 - 436 .

Houston Y, Lindsay JO, Jenkins H, McCartney S, Ahmad T, Arnott I, Croft N, Russell R et al. ( 2012 ) . Perspectives of transition care in inflammatory bowel disease: A survey . Gastrointestinal Nursing vol. 10 , ( 1 ) 30 - 35 .

Rao A, Kamperidis N, Koodun Y, Naik S, Croft NM, Sanderson IR ( 2012 ) . RESPONSE TO ENTERAL NUTRITION PREDICTS INCREASED LENGTH OF REMISSION IN CHILDREN WITH CROHN'S DISEASE . GUT . vol. 61 , A239 - A239 .

Sebastian S, Jenkins H, McCartney S, Ahmad T, Arnott I, Croft N, Russell R, Lindsay JO ( 2012 ) . The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and paediatric gastroenterologists . JOURNAL OF CROHNS & COLITIS vol. 6 , ( 8 ) 830 - 844 .

Goodhand J, Hedin CR, Croft NM, Lindsay JO ( 2011 ) . Adolescents with IBD: the importance of structured transition care . J Crohns Colitis vol. 5 , ( 6 ) 509 - 519 .

Goodhand JR, Tshuma N, Rao A, Kotta S, Wahed M, Croft NM, Sanderson IR, Epstein J et al. ( 2011 ) . Do children with IBD really respond better than adults to thiopurines? . J Pediatr Gastroenterol Nutr vol. 52 , ( 6 ) 702 - 707 .

Sebastian S, Jenkins H, Arnott I, Croft N, Ahmad T, McCartney S, Russell RK, Lindsay JO ( 2011 ) . Barriers to transition care in inflammatory bowel disease: a survey of adult and paediatric gastroenterologists in the UK . Gut . vol. 60 ,

Vossenkämper A, Marchès O, Fairclough PD, Warnes G, Stagg AJ, Lindsay JO, Evans PC, Luong LA et al. ( 2010 ) . Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE . J Immunol vol. 185 , ( 7 ) 4118 - 4127 .

Goodhand J, Dawson R, Hefferon M, Tshuma N, Swanson G, Wahed M, Croft NM, Lindsay JO ( 2010 ) . Inflammatory bowel disease in young people: the case for transitional clinics . Inflamm Bowel Dis vol. 16 , ( 6 ) 947 - 952 .

Rao A, Tshuma NB, Goodhand JR, Wahed M, Croft NM, Epstein J, Sanderson IR ( 2010 ) . RESPONSE TO AZATHIOPRINE IN ADULTS AND CHILDREN WITH INFLAMMATORY BOWEL DISEASE IS COMPARABLE WHEN PHENOTYPE IS CONTROLLED . J PEDIATR GASTR NUTR . vol. 50 , E112 - E112 .

Wilson DC, Thomas AG, Croft NM, Newby E, Akobeng AK, Sawczenko A, Fell JME, Murphy MS et al. ( 2010 ) . Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease . J Pediatr Gastroenterol Nutr vol. 50 Suppl 1 , S14 - S34 .

Goodhand J, Tang JW, Naik S, Croft N, Lindsay JO ( 2009 ) . W1115 Infliximab Use in Adolescents with Inflammatory Bowel Disease . Gastroenterology vol. 136 , ( 5 ) a - 657 .

Goodhand J, Tang J, Naik S, Croft NM, Lindsay JO ( 2009 ) . INFLIXIMAB USE IN ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE . GUT . vol. 58 , A63 - A64 .

Goodhand J, Swanson G, Hefferon M, Dawson R, Croft NM, Lindsay J ( 2009 ) . P004 - Specialist transitional clinics for adolescents with IBD limit exposure to diagnostic radiation . Journal of Crohn's and Colitis vol. 3 , ( 1 ) s12 - s12 .

Goodhand J, Tang J, Naik S, Croft NM, Lindsay J ( 2009 ) . P207 - Infliximab use in adolescents with IBD . Journal of Crohn's and Colitis vol. 3 , ( 1 ) s92 - s92 .

Goodhand J, Tang JW, Naik S, Croft N, Lindsey JO ( 2009 ) . Infliximab Use in Adolescents with Inflammatory Bowel Disease . GASTROENTEROLOGY . vol. 136 , A657 - A657 .

Newby EA, Croft NM, Green M, Hassan K, Heuschkel RB, Jenkins H, Casson DH ( 2008 ) . Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases . J Pediatr Gastroenterol Nutr vol. 46 , ( 5 ) 539 - 545 .

Dawson R, Hefferon M, Croft N, Lindsay JO ( 2008 ) . T1201 IBD in Adolescents: A Case Control Study of Disease Extent and Therapeutic Strategy . Gastroenterology vol. 134 , ( 4 ) a - 506 .

Croft NM ( 2008 ) . Gluten-free diets in celiac disease: does life mean life? . Gastroenterology vol. 134 , ( 3 ) 883 - 885 .

Naik S, Smith F, Ho J, Croft NM, Domizio P, Price E, Sanderson IR, Meadows NJ ( 2008 ) . Staphylococcal enterotoxins G and I, a cause of severe but reversible neonatal enteropathy . Clin Gastroenterol Hepatol vol. 6 , ( 2 ) 251 - 254 .

Dawson R, Hefferon M, Croft N, Lindsay JO ( 2008 ) . IBD in adolescents: A case control study of disease extent and therapeutic strategy . GASTROENTEROLOGY vol. 134 , ( 4 ) A506 - A506 .

Seerat I, Croft NM, Hickey A, Longhurst H ( 2008 ) . IGG antibodies to foods are of no relevance to IGE mediated food allergy . GUT . vol. 57 , A87 - A87 .

Croft NM ( 2008 ) . Ulcerative and Indeterminate Colitis . Walker's pediatric gastrointestinal disease , Editors: Kleinman, RE, Goulet, O, Sanderson, IR, Sherman, PM et al. , Edition. 5th Revised edition , B.C. Decker ( Hamilton ),

Karuppaswamy S, Croft N ( 2007 ) . A case of multiple food allergies . CLINICAL AND EXPERIMENTAL ALLERGY . vol. 37 , 1876 - 1876 .

Daley A, Randall R, Darsley M, Choudhry N, Thomas N, Sanderson IR, Croft NM, Kelly P ( 2007 ) . Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation . Gut vol. 56 , ( 11 ) 1550 - 1556 .

Di Sabatino A, Pickard KM, Gordon JN, Salvati V, Mazzarella G, Beattie RM, Vossenkaemper A, Rovedatti L et al. ( 2007 ) . Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease . Gastroenterology vol. 133 , ( 4 ) 1175 - 1187 .

Croft N, MACDONALD T, Monteleone G, Troncone R, Corazza GR, Stagg AG, Leakey NAM, Vossenkaemper A et al. ( 2007 ) . Evidence for the role of interferon-Ą production by dendritic cells in the Th1 response in celiac disease . Gastroenterology vol. 133 , 1175 - 87 .

Croft NM ( 2007 ) . Biologicals move into the esophagus . Gastroenterology vol. 133 , ( 1 ) 358 - 360 .

Köglmeier J, Croft N ( 2007 ) . How to prevent growth failure in children . Clinical Dilemmas in Inflammatory Bowel Disease ,

Beattie RM, Croft NM, Fell JM, Afzal NA, Heuschkel RB ( 2006 ) . Inflammatory bowel disease . Arch Dis Child vol. 91 , ( 5 ) 426 - 432 .

Croft NM ( 2006 ) . Phospholipid in UC: novel, safe and works--is it too good to be true? . Gastroenterology vol. 130 , ( 3 ) 1003 - 1004 .

Afzal NA, Hans-Joerg L, Mills S, Green M, Naik S, Meadows N, Sanderson I, Croft N ( 2006 ) . Inflammatory bowel disease phenotype in British children of South Asian origin . GASTROENTEROLOGY . vol. 130 , A215 - A215 .

Kamal-Uddin S, Croft NM ( 2006 ) . Rotavirus vaccines: The wheel has turned . Gastroenterology vol. 131 , ( 4 ) 1352 - 1354 .

Sawczenko A, Azooz O, Paraszczuk J, Idestrom M, Croft NM, Savage MO, Ballinger AB, Sanderson IR ( 2005 ) . Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children . Proc Natl Acad Sci U S A vol. 102 , ( 37 ) 13260 - 13265 .

Croft NM, Hodges M ( 2005 ) . IgM: mucosal response in acute diarrhoeal disease of infants . Scand J Gastroenterol vol. 40 , ( 8 ) 965 - 971 .

Sanderson IR, Croft NM ( 2005 ) . The anti-inflammatory effects of enteral nutrition . JOURNAL OF PARENTERAL AND ENTERAL NUTRITION . vol. 29 , S134 - S140 .

Ho J, Croft N, Akanle A ( 2005 ) . Bone mineral density at diagnosis in paediatric inflammatory bowel disease . BONE . vol. 36 , S86 - S86 .

Dogra H, Kruidenier L, Croft NM, Sanderson IR, Wilson JW ( 2005 ) . Butyrate regulates the expression of the intestinal epithelial stem cell marker, Musashi-1 . GASTROENTEROLOGY . vol. 128 , A279 - A279 .

Croft NM ( 2005 ) . IgG food antibodies and irritating the bowel . Gastroenterology vol. 128 , ( 4 ) 1135 - 1136 .

Dogra H, Kruidenier L, Sanderson IR, Croft NM, Wilson JW ( 2005 ) . Luminal regulation of intestinal epithelial stem cell fate . GUT . vol. 54 , A78 - A78 .

Sawczenko A, Idestrom M, Ballinger AB, Croft NM, Sanderson IR ( 2005 ) . The -174 G/c interleukin-6 polymorphism determines growth failure in paediatric onset Crohn's disease . GASTROENTEROLOGY . vol. 128 , A39 - A39 .

Sawczenko A, Idestrom M, Ballinger AB, Croft NM, Sanderson IR ( 2005 ) . The-174 G/C interleukin-6 polymorphism determines growth failure in paediatric onset Crohn's disease . GUT . vol. 54 , A97 - A98 .

Croft NM ( 2004 ) . The spice of life for cystic fibrosis . Gastroenterology vol. 127 , ( 5 ) 1639 - 1640 .

Afzal NA, Mills S, Naik S, Sanderson I, Meadows N, Croft N ( 2004 ) . P0652 INFLAMMATORY BOWEL DISEASE IN ASIAN CHILDREN RESIDENT IN UK . Journal of Pediatric Gastroenterology and Nutrition vol. 39 , ( Supplement 1 )

Rawat DJ, Yazaki ET, Meadows NM, Croft NM, Evans DF ( 2004 ) . P1004 CAN ELECTROGASTROGRAPHY REPLACE GASTRIC EMPTYING FOR CHILDREN WITH GASTRIC DYSFUNCTION? . Journal of Pediatric Gastroenterology and Nutrition vol. 39 , ( Supplement 1 )

Arthur SK, Nadeem A, Rawat D, Smith F, Wiles K, Croft N, Evans DF, Meadows N ( 2004 ) . An appraisal of the impact of manometry on the management of children with feeding difficulties . GUT . vol. 53 , A62 - A62 .

Yazaki E, Hirata M, Rawat D, Croft N, Meadows N, Evans DF ( 2004 ) . Can electrogastrography replace gastric emptying for children with gastric dysfunction? . GUT . vol. 53 , A113 - A113 .

Croft NM, Paraszczuk J, Ali E, Wilson JW, Jones SA, Naik S, Sanderson IR ( 2004 ) . Is there a relationship between NOD2 polymorphism and response to polymeric enteral feed in children with Crohn's disease? . GUT . vol. 53 , A32 - A32 .

Daley AC, Croft N, Randall R, Kelly P ( 2004 ) . Lack of a systemic immune response to oral vaccination does not indicate lack of mucosal immunity . GUT . vol. 53 , A72 - A72 .

Bannerjee K, Camacho-Hübner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, Sanderson IR, Croft NM ( 2004 ) . Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease . J Pediatr Gastroenterol Nutr vol. 38 , ( 3 ) 270 - 275 .

Escher JC, European Collaborative Research Group on Budesonide in Paediatric IBD ( 2004 ) . Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial . Eur J Gastroenterol Hepatol vol. 16 , ( 1 ) 47 - 54 .

Akanle OA, Ho J, Muhiddin K, Admans L, Croft NM, Spyrou NM ( 2004 ) . Elemental composition of hair and bone density measurements at diagnosis in paediatric inflammatory bowel disease . J RADIOANAL NUCL CH vol. 259 , ( 2 ) 355 - 360 .

Fuchs G, Ahmed T, Araya M, Baker S, Croft N, Weaver L ( 2004 ) . Malnutrition: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition . JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION . vol. 39 , S670 - S677 .

Croft NM, Ho J, Akanle OA, Savage MO, Sanderson IR ( 2003 ) . Decreased bone mineral density at diagnosis in paediatric inflammatory bowel disease . GUT . vol. 52 , A21 - A21 .

Naik S, Smith F, Ho J, Croft NM, Domizio P, Price E, Sanderson IR, Meadows NJ ( 2003 ) . Staphylococcal enterotoxin G and I: A novel cause of severe neonatal enteropathy? . GUT . vol. 52 , A101 - A101 .

Naik S, Smith F, Ho J, Croft N, Domizio P, Sanderson I, Meadows N, Price E ( 2003 ) . Staphylococcal enterotoxins G and I: A cause of severe neonatal enteropathy? . Gastroenterology . vol. 124 ,

Sawczenko A, Ballinger AB, Croft NM, Sanderson IR, Savage MO ( 2003 ) . Adult height in patients with early onset of Crohn's disease . Gut vol. 52 , ( 3 ) 454 - 455 .

CROFT NM, Pender SL, Salvati M, Monteleone G, Holloway J, Fairclough PD, MacDonald TT ( 2003 ) . Activated STAT4 and a functional role for IL-12 in human Peyer's patches . J. Immunol. vol. 170 , ( 1 ) 300 - 307 .

CROFT NM ( 2003 ) . Management of Crohn's disease in children . Management of Crohn's disease; Greig ER, Rampton DS, eds. , Martin Dunitz ( London and New York ),

Ali E, Crouchman P, Meadows N, Sanderson IR, Croft NM ( 2002 ) . Outcome of enteral feeding for newly diagnosed Crohn's disease . GUT . vol. 50 , A71 - A72 .

Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT ( 2001 ) . Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease . J Clin Invest vol. 108 , ( 4 ) 601 - 609 .

Thapar N, Croft N, Meadows N, Evans D ( 2001 ) . ACHALASIA IN CHILDREN: INCREASING INCIDENCE? EXPERIENCE OF BOTULINUM TOXIN THERAPY . Journal of Pediatric Gastroenterology and Nutrition vol. 32 ,

Thapar N, Croft N, Meadows N, Evans D ( 2001 ) . Achalasia in children: An increasing problem? Endoscopic use of botulinum toxin and experience from a single UK centre . GASTROINTEST ENDOSC . vol. 53 , AB204 - AB204 .

Kelly EJ, Naik S, Sanderson IR, Croft NM ( 2001 ) . Elemental diet modulates the inflammatory response of enterocytes . GASTROENTEROLOGY . vol. 120 , A674 - A675 .

Croft NM ( 2001 ) . Intestinal inflammation in cystic fibrosis . ARCH DIS CHILD vol. 84 , ( 4 ) 374 - 375 .

MacKay WG, Shepherd AJ, Doherty CP, Hossack M, Williams CL, Weaver LT ( 2001 ) . 340. FAMILY SIZE, SIBLINGS, SOCIOECONOMIC STATUS AND CHILDHOOD RISK OF HELICOBACTER PYLORI . Gut vol. 48 , ( suppl 1 )

Thapar N, Croft NM, Meadows N, Evans D ( 2001 ) . Achalasia in children: An increasing and more severe problem? A single centre experience . GUT . vol. 48 , A91 - A91 .

Croft NM, Kelly EJ, Bannerjee K, Dryhurst K, Sanderson I ( 2001 ) . Diets can modulate the inflammatory response in vivo and in vitro . GUT . vol. 48 , A2 - A2 .

Ballinger AB, Camacho-Hübner C, Croft NM ( 2001 ) . Growth failure and intestinal inflammation . QJM vol. 94 , ( 3 ) 121 - 125 .

Kumberova A, CROFT NM, MacDonald TT, Steer HW, Monteleone G, McKenzie C ( 2001 ) . Blocking Smad7 restores TGF-beta1 signalling in chronic inflammatory bowel disease . J. Clin. Invest. vol. 108 , ( 4 ) 601 - 609 .

CROFT NM ( 2001 ) . Current treatment of IBD in children. [Review] . Hospital Prescriber Europe vol. 2 , 29 - 31 .

Croft NM, Howatson AG, Ling SC, Nairn L, Evans TJ, Weaver LT ( 2000 ) . Microvillous inclusion disease: An evolving condition . Journal of Pediatric Gastroenterology and Nutrition vol. 31 , ( SUPPL. 2 ) 185 - 189 .

Smyth RL, Croft NM, O'Hea U, Marshall TG, Ferguson A ( 2000 ) . Intestinal inflammation in cystic fibrosis . Archives of Disease in Childhood vol. 82 , ( 5 ) 394 - 399 .

Bannerjee K, Croft NM, Babinska K, Camachno-Hubner C, Savage MO, Sanderson IR ( 2000 ) . The influence of enteral feeding on growth factors, inflammation and nutrition in children with Crohn's disease . Gastroenterology . vol. 118 ,

Croft NM, Ferguson A ( 2000 ) . High intraluminal fluid flow increases intestinal IgA output . Scandinavian Journal of Gastroenterology vol. 35 , ( 7 ) 726 - 731 .

Croft NM, Hodges M, Ferguson A, Kabba LH ( 1998 ) . Igm: The primary immune response in acute diarrhoea . Pediatric Research vol. 44 , ( 3 )

Croft NM ( 1996 ) . Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis . Postgraduate Medical Journal vol. 72 , ( 3332 )

Croft N, Heaf D ( 1996 ) . Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis - Discussion . POSTGRADUATE MEDICAL JOURNAL vol. 72 , S36 - S36 .

Doull I, Langton-Hewer S, Croft NM, Marshall TG, Ferguson A ( 1996 ) . Gut inflammation in children with cystic fibrosis on high-dose enzyme supplementation [8] . Lancet vol. 347 , ( 8997 )

Marshall TG, Croft N, Ferguson A ( 1995 ) . Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements . The Lancet vol. 346 , ( 8985 ) 1265 - 1267 .

Ferguson A, Humphreys KA, Croft NM ( 1995 ) . Technical report: Results of immunological tests on faecal extracts are likely to be extremely misleading . Clinical and Experimental Immunology vol. 99 , ( 1 ) 70 - 75 .

Croft NM, Jacob AJ, Godman MJ, Boon NA, Mok JYQ ( 1993 ) . Cardiac dysfunction in paediatric HIV infection . Journal of Infection vol. 26 , ( 2 ) 191 - 194 .

Lyall EGH, Langdale‐Brown B, Eden OB, Mok JYQ, Croft NM ( 1993 ) . Ewing's sarcoma in a child with human immunodeficiency virus (type 1) infection . Medical and Pediatric Oncology vol. 21 , ( 2 ) 127 - 131 .

Croft N, Yap PL, Mok JYQ, Hague RA, Burns SM ( 1992 ) . Zidovudine therapy in combination with intravenous immunoglobulin HIV infected children . Scottish Medical Journal vol. 37 , ( 5 ) 138 - 141 .